A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

Summary

To evaluate the efficacy of QY201 tablets in the treatment of adult patients with moderate to severe atopic dermatitis (AD).

Timeline

Start

2025-03-12

Primary completion

2027-05-18

Completion

2027-07-19

Drugs

Indications